Stay updated on Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Adds new organizational/time context and expands IPD data sharing details while removing the previous sharing URLs and streamlined criteria.
    Difference
    11%
    Check dated 2025-10-13T21:02:21.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now communicates an operating-status notice and that the NIH Clinical Center is open, along with where to verify status, and it updates the version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T16:04:43.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T09:55:49.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page updates from v3.0.1 to v3.0.2; the 'Back to Top' link was removed; no other substantive content changes are indicated.
    Difference
    0.2%
    Check dated 2025-09-15T00:19:40.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T20:37:58.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific facility names and locations across various countries, while also removing previous location terms and references to the Russian Federation. The revision number has been updated to v3.0.0.
    Difference
    6%
    Check dated 2025-08-31T12:57:49.000Z thumbnail image

Stay in the know with updates to Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.